Autoimmune Diseases  >>  MTRX 1011A  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MTRX 1011A / Tolerx, Roche
NCT00718588: A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MTRX1011A in Patients With Rheumatoid Arthritis

Terminated
1
66
US
MTRX1011A
Genentech, Inc.
Rheumatoid Arthritis
12/09
 

Download Options